164 related articles for article (PubMed ID: 15208662)
1. Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells.
You L; He B; Xu Z; Uematsu K; Mazieres J; Mikami I; Reguart N; Moody TW; Kitajewski J; McCormick F; Jablons DM
Oncogene; 2004 Aug; 23(36):6170-4. PubMed ID: 15208662
[TBL] [Abstract][Full Text] [Related]
2. An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth.
You L; He B; Xu Z; Uematsu K; Mazieres J; Fujii N; Mikami I; Reguart N; McIntosh JK; Kashani-Sabet M; McCormick F; Jablons DM
Cancer Res; 2004 Aug; 64(15):5385-9. PubMed ID: 15289346
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells.
You L; He B; Uematsu K; Xu Z; Mazieres J; Lee A; McCormick F; Jablons DM
Cancer Res; 2004 May; 64(10):3474-8. PubMed ID: 15150100
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling pathway in non-small cell lung cancer.
Stewart DJ
J Natl Cancer Inst; 2014 Jan; 106(1):djt356. PubMed ID: 24309006
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Wnt-1 monoclonal antibody in sarcoma cells.
Mikami I; You L; He B; Xu Z; Batra S; Lee AY; Mazieres J; Reguart N; Uematsu K; Koizumi K; Jablons DM
BMC Cancer; 2005 May; 5():53. PubMed ID: 15913453
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells.
He B; You L; Uematsu K; Xu Z; Lee AY; Matsangou M; McCormick F; Jablons DM
Neoplasia; 2004; 6(1):7-14. PubMed ID: 15068666
[TBL] [Abstract][Full Text] [Related]
7. Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer.
Yang L; Chen Y; Cui T; Knösel T; Zhang Q; Albring KF; Huber O; Petersen I
Carcinogenesis; 2012 Oct; 33(10):1863-70. PubMed ID: 22791817
[TBL] [Abstract][Full Text] [Related]
8. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression.
Uematsu K; He B; You L; Xu Z; McCormick F; Jablons DM
Oncogene; 2003 Oct; 22(46):7218-21. PubMed ID: 14562050
[TBL] [Abstract][Full Text] [Related]
9. Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation.
Winn RA; Marek L; Han SY; Rodriguez K; Rodriguez N; Hammond M; Van Scoyk M; Acosta H; Mirus J; Barry N; Bren-Mattison Y; Van Raay TJ; Nemenoff RA; Heasley LE
J Biol Chem; 2005 May; 280(20):19625-34. PubMed ID: 15705594
[TBL] [Abstract][Full Text] [Related]
10. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
Lv L; Wan C; Chen B; Li M; Liu Y; Ni T; Yang Y; Liu Y; Cong X; Mao G; Xue Q
J Cell Biochem; 2014 Jan; 115(1):81-92. PubMed ID: 23904219
[TBL] [Abstract][Full Text] [Related]
11. 2,3,6-Trisubstituted quinoxaline derivative, a small molecule inhibitor of the Wnt/beta-catenin signaling pathway, suppresses cell proliferation and enhances radiosensitivity in A549/Wnt2 cells.
Lee SB; Gong YD; Park YI; Dong MS
Biochem Biophys Res Commun; 2013 Feb; 431(4):746-52. PubMed ID: 23348226
[TBL] [Abstract][Full Text] [Related]
12. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
[TBL] [Abstract][Full Text] [Related]
13. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
14. Wnt-5a regulates proliferation in lung cancer cells.
Huang Y; Liu G; Zhang B; Xu G; Xiong W; Yang H
Oncol Rep; 2010 Jan; 23(1):177-81. PubMed ID: 19956879
[TBL] [Abstract][Full Text] [Related]
15. Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways.
Janmaat ML; Kruyt FA; Rodriguez JA; Giaccone G
Clin Cancer Res; 2003 Jun; 9(6):2316-26. PubMed ID: 12796401
[TBL] [Abstract][Full Text] [Related]
16. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
Zhang K; Li Y; Liu W; Gao X; Zhang K
Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
[TBL] [Abstract][Full Text] [Related]
17. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
Hu Z; Zeng Q; Zhang B; Liu H; Wang W
Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer.
Krysan K; Dalwadi H; Sharma S; Põld M; Dubinett S
Cancer Res; 2004 Sep; 64(18):6359-62. PubMed ID: 15374938
[TBL] [Abstract][Full Text] [Related]
19. Nuciferine, extracted from Nelumbo nucifera Gaertn, inhibits tumor-promoting effect of nicotine involving Wnt/β-catenin signaling in non-small cell lung cancer.
Liu W; Yi DD; Guo JL; Xiang ZX; Deng LF; He L
J Ethnopharmacol; 2015 May; 165():83-93. PubMed ID: 25698245
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three approaches for inhibiting insulin-like growth factor I receptor and their effects on NSCLC cell lines in vitro.
Cosaceanu D; Carapancea M; Alexandru O; Budiu R; Martinsson HS; Starborg M; Vrabete M; Kanter L; Lewensohn R; Dricu A
Growth Factors; 2007 Feb; 25(1):1-8. PubMed ID: 17454144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
